What’s Important for Success of Multi-Sector Consortium in Regenerative Medicine
Recently, Japan has given two prominent topics, bad and good, to the global regenerative medicine community. The former is the over-promoted but fabricated STAP stem cell papers, and the latter is a rather unusual bold move by Japanese government to start flexible and relaxed regulation to advance the stem cell-based therapy. Then, what are happening in Japan?
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>